Controlled Intracellular Polymerization for Cancer Treatment.
Yichuan ZhangQuan GaoWeishuo LiRongkun HeLiwei ZhuQianjin LianLiang WangYang LiMark BradleyJin GengPublished in: JACS Au (2022)
Numerous prodrugs have been developed and used for cancer treatments to reduce side effects and promote efficacy. In this work, we have developed a new photoactivatable prodrug system based on intracellular photoinduced electron transfer-reversible addition-fragmentation chain-transfer (PET-RAFT) polymerization. This unique polymerization process provided a platform for the synthesis of structure-predictable polymers with well-defined structures in living cells. The intracellularly generated poly( N , N -dimethylacrylamide)s were found to induce cell cycle arrest, apoptosis, and necroptosis, inhibit cell proliferation, and reduce cancer cell motilities. This polymerization-based "prodrug" system efficiently inhibits tumor growth and metastasis both in vitro and in vivo and will promote the development of targeted and directed cancer chemotherapy.
Keyphrases
- cell cycle arrest
- electron transfer
- living cells
- papillary thyroid
- cell proliferation
- cell death
- pi k akt
- cancer therapy
- squamous cell
- fluorescent probe
- computed tomography
- endoplasmic reticulum stress
- cell cycle
- reactive oxygen species
- signaling pathway
- positron emission tomography
- high resolution
- squamous cell carcinoma
- drug delivery
- lymph node metastasis
- locally advanced
- pet ct
- radiation therapy
- pet imaging
- childhood cancer
- single cell